Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mennecier

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2000
Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II studyB Mennecier, P Jacoulet, A Dubiez, et al.
Revue Des Maladies Respiratoires|April 3, 2010
[Small cell lung cancer and anti-Hu syndrome]N Prim, B Mennecier, C Behr, et al.
Revue De Pneumologie Clinique|April 19, 2011
[Muscular metastasis from primary lung cancer: about seven cases]L Hajouji, B Mennecier, D de la Haye Saint-Hilaire, et al.
Revue De Pneumologie Clinique|December 6, 2011
[Atypical metastatic site of lung adenocarcinoma]L Sakhri, B Mennecier, D Jacqmin, et al.
Revue De Pneumologie Clinique|November 1, 2006
[Pituitary metastases from lung cancer. Five cases]A-C Métivier, B Mennecier, F Grunenberger, et al.
Revue Des Maladies Respiratoires|September 24, 2018
[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer]X Mignard, M Antoine, D Moro-Sibilot, et al.
The European Respiratory Journal|February 3, 2009
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-upA-M Ruppert, M Beau-Faller, A Neuville, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]N Girard, V Gounant, B Mennecier, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Lung Cancer (Amsterdam, Netherlands)|March 4, 2000
Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II studyB Mennecier, P Jacoulet, A Dubiez, et al.
Revue Des Maladies Respiratoires|April 3, 2010
[Small cell lung cancer and anti-Hu syndrome]N Prim, B Mennecier, C Behr, et al.
Revue De Pneumologie Clinique|April 19, 2011
[Muscular metastasis from primary lung cancer: about seven cases]L Hajouji, B Mennecier, D de la Haye Saint-Hilaire, et al.
Revue De Pneumologie Clinique|December 6, 2011
[Atypical metastatic site of lung adenocarcinoma]L Sakhri, B Mennecier, D Jacqmin, et al.
Revue De Pneumologie Clinique|November 1, 2006
[Pituitary metastases from lung cancer. Five cases]A-C Métivier, B Mennecier, F Grunenberger, et al.
Revue Des Maladies Respiratoires|September 24, 2018
[IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer]X Mignard, M Antoine, D Moro-Sibilot, et al.
The European Respiratory Journal|February 3, 2009
EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-upA-M Ruppert, M Beau-Faller, A Neuville, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF)S Couraud, A B Cortot, L Greillier, et al.
Revue Des Maladies Respiratoires|January 28, 2014
[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française]N Girard, V Gounant, B Mennecier, et al.
Pageof 3